Bollard Group LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $4.37 Billion distributed in 295 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Boston Scientific Corp with a value of $2.16B, Eli Lilly & CO with a value of $196M, Amazon Com Inc with a value of $171M, Spdr S&P 500 ETF Tr Call Optio with a value of $158M, and Microsoft Corp with a value of $157M.

Examining the 13F form we can see an increase of $566M in the current position value, from $3.81B to 4.37B. Also it can be appreciated an additional of 26 stocks purchases and 1 closed positions.

Bollard Group LLC is based out at Boston, MA

Below you can find more details about Bollard Group LLC portfolio as well as his latest detailed transactions.

Portfolio value $4.37 Billion
Healthcare: $2.44 Billion
Technology: $367 Million
Energy: $294 Million
Consumer Cyclical: $203 Million
Utilities: $191 Million
Industrials: $175 Million
Financial Services: $159 Million
Communication Services: $145 Million
Other: $228 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 295
  • Current Value $4.37 Billion
  • Prior Value $3.81 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 26 stocks
  • Additional Purchases 197 stocks
  • Sold out of 1 stocks
  • Reduced holdings in 19 stocks
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.